Brief: Kiora Pharmaceuticals Says Recent Strategic Partnership And Financing Expected To Fund Operations Through 2026
25/03/2024 13:26
March 25 (Reuters) - Kiora Pharmaceuticals Inc KPRX.O :
* KIORA PHARMACEUTICALS INC - RECENT STRATEGIC PARTNERSHIP
AND
FINANCING EXPECTED TO FUND OPERATIONS THROUGH 2026
* KIORA PHARMACEUTICALS INC - CONTINUES TO ADVANCE PIPELINE
OF
TREATMENTS FOR RARE RETINAL DISEASES
Source text for Eikon: ID:n0001372514-24-000027
Further company coverage: KPRX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Kiora Pharmaceuticals
See all newsKiora Pharmaceuticals, Inc. reports results for the quarter ended June 30 - Earnings Summary
Kiora Pharmaceuticals, Inc. expected to post a loss of 62 cents a share - Earnings Preview
Brief: Kiora Pharmaceuticals Inc - Enters Securities Purchase Agreement On April 3, 2026 - SEC Filing
Kiora Pharmaceuticals posts 2025 net loss as expenses rise
Brief: Kiora Pharmaceuticals Files For Mixed Shelf Offering Of Up To $100 Million- SEC Filing